ClinicalTrials.gg
Enrolling by invitationNCT06782087Updated Sep 25, 2025

A Comparative Study Between the Efficacy of Diode Laser and Nano-chitosan Gel on Activation of Non-vital in- Office Bleaching Agent

A Phase 1 interventional study of nano chitosan in Tooth Discoloration, sponsored by Misr University for Science and Technology. Enrolling by invitation at 1 site in Egypt. Open to participants aged 18 Years to 40 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-25.

Sponsored by Misr University for Science and Technology · Phase 1, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as enrolling by invitation.
Phase
Phase 1
Study type
Interventional
Enrollment
42
Allocation
Not applicable
Ages
18 Years to 40 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 15 studies in Tooth Discoloration with a site in Egypt — 4 open to participants now, 6 under way, none of them phase 3. Tooth Discoloration · Egypt.

Planned enrollment
5th of 15
42 · median 20
Started
2025
with 2 others
Phase 1
2 of 15
2 open now
Registered
10th of 15
by date
Lead sponsor
3 of 15
Misr University for Science and Technology

Among the 15 studies in Tooth Discoloration with a site in Egypt, this one is the 5th largest by planned enrollment, is one of 3 that started in 2025, is one of 2 in phase 1, and was the 10th registered.

By phase

15 studies; the count open now beside each. This study's row is marked.

No phase12 · 2 open
Phase 1this study2 · 2 open
Phase 31 · 0 open

By the year they started

First in 2017; this study’s year is marked. 3 started in 2025.

Size and results

Median enrollment 20 across the 15 interventional studies. Of the 7 that completed or were terminated, 0 (0%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 15 studies in Tooth Discoloration with a site in Egypt, or all of them as a file.
02

Study summary

The growing demand for white smile between patients has increased over recent years, the development of techniques and improvement of materials permits searching for beautiful natural smile.

The discoloration of teeth might be intrinsic, extrinsic, or combined. A variety of commercial bleaching agents is available. The most common substances used are carbamide peroxide or hydrogen peroxide or a mixture of sodium perborate and hydrogen peroxide.

Read the detailed description

The aim of the study is to assess the effectiveness of two different in-office bleaching materials carbamide peroxide alone and carbamide peroxide with Chitosan nanoparticles Using diode laser as an activator Regarding tooth whitening and color stability 1 Day , 1 weeks, 1 month after treatment using Vita easy shade.

03

Conditions studied

  • Tooth Discoloration

Browse trials for

Keywords

  • chitosan nanoparticles
  • Diode laser
  • carbamide peroxide
  • nonvital teeth bleaching
04

Who can participate

Ages eligible
18 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • discolored crown, non-vital or endodontically treated upper central and lateral incisors
  • previous endodontic treatment performed two or more years earlier.

Exclusion criteria

Exclusion Criteria:

  • caries on upper central and lateral incisors, inadequate fillings, and progressive periodontal disease.
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Sequential assignment
Masking
None (open label)
Enrollment
42 participants (estimated)

Study arms

  • Other
    peroxides and sodium perborate and 980nm diode laser.

    peroxides and sodium perborate + 980nm diode laser.

    Drug: nano chitosan

Interventions

  • Drugnano chitosan

    nano chitosan

06

What researchers measure

Primary outcomes

  1. Color change

    these assessments were performed for 1 day, 1 week, and 1 month after treatment with Vita easy shade obtaining difference ∆E\* values using colorcoordinates CIE L\*, a\* and b\*

    Time frame: these assessments were performed for 1 day, 1 week, and 1 month after treatment with Vita easy shade.

  2. color change using digital vita easy shade guide

    color change using digital vita easy shade guide

    Time frame: 1 day , 1 week , 1 month

07

Study locations

1 site
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2025; primary completion for Oct 2025, 0 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 23, 2024
First posted
Jan 17, 2025
StartEst.
Oct 15, 2025
Primary completionEst.
Oct 30, 2025
CompletionEst.
Oct 30, 2025
Last update
Sep 25, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 25, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06782087
Lead sponsor
Misr University for Science and Technology
Responsible party
Silvia Sabry (lecturer of conservative dentidtry, Misr University for Science and Technology) — Principal investigator
First posted
Jan 17, 2025
Start date
Oct 15, 2025 (estimated)
Primary completion
Oct 30, 2025 (estimated)
Completion
Oct 30, 2025 (estimated)
Last update
Sep 25, 2025

Study contacts

Manal abd el baky A dr, phd
study director · Lecturer in conservative surgery departement

Oversight

Data monitoring committee
Yes
FDA-regulated drug
Yes
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion